Clinical Medicine.
Department of General Surgery, Taihe Hospital, Hubei University of Medicine, Shiyan, People's Republic of China.
Int J Surg. 2024 May 1;110(5):3021-3029. doi: 10.1097/JS9.0000000000001185.
Postoperative mortality plays an important role in evaluating the surgical safety of esophagectomy. Although postoperative mortality after esophagectomy is partly influenced by the yearly hospital surgical case volume (hospital volume), this association remains unclear.
Studies assessing the association between hospital volume and postoperative mortality in patients who underwent esophagectomy for esophageal cancer were searched for eligibility. Odds ratios were pooled for the highest versus lowest categories of hospital volume using a random effects model. The dose-response association between hospital volume and the risk of postoperative mortality was analyzed. The study protocol was registered with PROSPERO.
Fifty-six studies including 385 469 participants were included. A higher-volume hospital significantly reduced the risk of postesophagectomy mortality by 53% compared with their lower-volume counterparts (odds ratio, 0.47; 95% CI: 0.42-0.53). Similar results were found in subgroup analyses. Volume-outcome analysis suggested that postesophagectomy mortality rates remained roughly stable after the hospital volume reached a plateau of 45 esophagectomies per year.
Higher-volume hospitals had significantly lower postesophagectomy mortality rates in patients with esophageal cancer, with a threshold of 45 esophagectomies per year for a high-volume hospital. This remarkable negative correlation showed the benefit of a better safety in centralization of esophagectomy to a high-volume hospital.
术后死亡率在评估食管癌切除术的手术安全性方面起着重要作用。尽管食管癌切除术的术后死亡率部分受到医院手术年度病例量(医院量)的影响,但这种关联尚不清楚。
搜索评估接受食管癌切除术的患者的医院量与术后死亡率之间关联的研究,以确定其是否符合入选标准。使用随机效应模型对最高和最低医院量类别进行了优势比的汇总。分析了医院量与术后死亡率风险之间的剂量-反应关系。该研究方案已在 PROSPERO 中注册。
共纳入 56 项研究,包括 385469 名参与者。与低量医院相比,高量医院显著降低了 53%的术后死亡率风险(优势比,0.47;95%CI:0.42-0.53)。亚组分析也得出了类似的结果。量效关系分析表明,每年实施 45 例以上食管癌切除术的医院,术后死亡率基本保持稳定。
在食管癌患者中,高量医院的术后死亡率显著降低,每年进行 45 例以上食管癌切除术的医院为高量医院。这种显著的负相关表明,将食管癌集中到高量医院进行手术可带来更好的安全性。